On November 13, The Journal of Clinical Lipidology published a manuscript co-authored by ADVI Health’s Michael S. Broder, MD, Irina Yermilov, MD, MPH, MS, Eunice Chang, PhD, Cynthia Campos, MPH, and Sarah Gibbs, MPH, alongside several other esteemed researchers.

The abstract, titled “Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America,” was meant to develop and validate a diagnostic score for North American patients based on signs, symptoms, and biochemical traits of FCS. Our #ADVIExperts used numerical scores that were attributed based upon the following: age, hypertriglyceridemia onset, body mass index, history of abdominal pain/pancreatitis, presence of secondary factors, triglyceride (TG) levels, ratio of TG/total cholesterol, and apolipoprotein B level.

See the full manuscript in The Journal of Clinical Lipidology.